Home » Sponsors Should Identify Methods to Avoid Missing Data in Trials
Sponsors Should Identify Methods to Avoid Missing Data in Trials
October 14, 2010
To avoid problems with missing data in clinical trials, sponsors should identify, before beginning a trial, methods to account for planning, conducting or analyzing results of a confirmatory study, according to a final guideline recently released by the European Medicines Agency (EMA). Includes the full text of European Medicines Agency Guideline
on Missing Data in Clinical Trials.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor